-transparent.png){kind=logo}
Both TGF beta 2 and 5 have been described in the South African clawed frog Xenopus laevis and have been cloned from the tadpole-derived fibroblast cell line, XTC. Because TGF beta has such a profound inhibitory effect on the mammalian immune system, this study was performed to determine whether TGF beta: (a) has any in vitro effects on the growth of Xenopus lymphoblasts, and (b) is produced by mitogen-activated Xenopus lymphocytes. Following stimulation with mitogen or alloantigen, T lymphocytes from Xenopus secrete a T-cell growth factor (TCGF) that is functionally homologous to mammalian interleukin-2 (IL-2). Both recombinant human TGF beta 1 and Xenopus TGF beta 5 inhibit TCGF-induced proliferation of Xenopus splenic blasts and this inhibition can be reversed with anti-pan TGF beta antiserum. The Xenopus mitogen-induced saturated ammonium sulfate precipitated TCGF-containing supernatant (SAS TCGF SN) also contains latent TGF beta as assayed on mink lung fibroblasts and Xenopus splenic blasts, and experiments utilizing anti-TGF beta antiserum showed that only TGF beta 5 is present in this supernatant.
L Haynes, and
N Cohen
January 1990,
The Journal of biological chemistry,
L Haynes, and
N Cohen
February 1998,
Gene,
L Haynes, and
N Cohen
April 2004,
British journal of plastic surgery,
L Haynes, and
N Cohen
January 1988,
European journal of immunology,
L Haynes, and
N Cohen
August 1998,
Biochemistry and molecular biology international,
L Haynes, and
N Cohen
March 1998,
The international journal of biochemistry & cell biology,
L Haynes, and
N Cohen
October 1990,
Sheng li ke xue jin zhan [Progress in physiology],
L Haynes, and
N Cohen
September 2005,
Autoimmunity reviews,
L Haynes, and
N Cohen
September 1996,
Journal of molecular and cellular cardiology,
L Haynes, and
N Cohen
October 1996,
American journal of respiratory and critical care medicine,
